A randomized controlled trial of metformin on left ventricular hypertrophy in patients with coronary artery disease without diabetes: the MET-REMODEL trial

Repurposing Metformin for Cardiovascular Disease

(2018) Graham Rena et al.   CIRCULATION

Acute vs Cumulative Benefits of Metformin use in Patients with Type 2 Diabetes and Heart Failure

(2018) Daniala L. Weir et al.   DIABETES OBESITY & METABOLISM

Effects of oral antidiabetic drugs on left ventricular mass in patients with type 2 diabetes mellitus: a network meta-analysis

(2018) Satoshi Ida et al.   Cardiovascular Diabetology

2018 ESC/ESH Guidelines for the management of arterial hypertension

(2018) Bryan Williams et al.   EUROPEAN HEART JOURNAL

Effects of metformin on blood pressure in nondiabetic patients

(2017) Long Zhou et al.   JOURNAL OF HYPERTENSION

Metformin effects on the heart and the cardiovascular system: A review of experimental and clinical data

(2017) L. Nesti et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Measurement and Clinical Significance of Biomarkers of Oxidative Stress in Humans

(2017) Ilaria Marrocco et al.   Oxidative Medicine and Cellular Longevity

The Effect of Metformin on Diastolic Function in Patients Presenting with ST-Elevation Myocardial Infarction

(2016) Lawien Al Ali et al.   PLoS One

Metformin and its Effects on Myocardial Dimension and Left ventricular hypertrophy in Normotensive patients with Coronary Heart Disease (The MET-REMODEL Study): Rationale and Design of the MET-REMODEL Study

(2015) Mohapradeep Mohan et al.   Cardiovascular Therapeutics

Impact of glucose-lowering drugs on cardiovascular disease in type 2 diabetes

(2015) Ele Ferrannini et al.   EUROPEAN HEART JOURNAL

Effect of Metformin on Left Ventricular Function After Acute Myocardial Infarction in Patients Without Diabetes

(2014) Chris P. H. Lexis et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD

(2013)   EUROPEAN HEART JOURNAL

High-Dose Allopurinol Reduces Left Ventricular Mass in Patients With Ischemic Heart Disease

(2013) Sushma Rekhraj et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial

(2013) David Preiss et al.   Lancet Diabetes & Endocrinology

Effects of metformin on markers of oxidative stress and antioxidant reserve in patients with newly diagnosed type 2 diabetes: A randomized clinical trial

(2012) Alireza Esteghamati et al.   CLINICAL NUTRITION

Effects of pioglitazone and metformin on vascular endothelial function in patients with type 2 diabetes treated with sulfonylureas

(2011) Katerina K Naka et al.   Diabetes & Vascular Disease Research

Left Ventricular Mass

(2010) Julio A. Chirinos et al.   HYPERTENSION

Diagnosis and Classification of Diabetes Mellitus

(2009)   DIABETES CARE

Pioglitazone Compared with Metformin Increases Pericardial Fat Volume in Patients with Type 2 Diabetes Mellitus

(2009) J. T. Jonker et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Insulin Resistance Is Highly Prevalent and Is Associated With Reduced Exercise Tolerance in Nondiabetic Patients With Heart Failure

(2009) Matlooba A. ALZadjali et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Clinical Impact of Left Ventricular Hypertrophy and Implications for Regression

(2009) Surya M. Artham et al.   PROGRESS IN CARDIOVASCULAR DISEASES

Left Ventricular Hypertrophy and Clinical Outcomes in Hypertensive Patients

(2008) L. M. Ruilope et al.   AMERICAN JOURNAL OF HYPERTENSION

Meta-analysis: Metformin Treatment in Persons at Risk for Diabetes Mellitus

(2008) Shelley R. Salpeter et al.   AMERICAN JOURNAL OF MEDICINE